Summary:
A single-dose, open-label, multi-center, randomized, 2-treatment crossover study to compare the pharmacokinetics, pharmacodynamics, safety and tolerability of acetylsalicylic acid powder for oral inhalation with non-enteric-coated chewable aspirin in adult subjects with obstructive or restrictive pulmonary function
Criteria:- Be 40 years old or older
- Be diagnosed with COPD or have a history of restrictive lung disease
- Be a current non-smoker
- Additional criteria apply
Qualified Participants May Receive:
- Study-related care at no cost
- Compensation up to $2,550 for time and trial-related travel expenses